NCT00685750 - Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 28, 2008

Primary Completion Date

December 17, 2013

Study Completion Date

December 17, 2013

Conditions

Lung Cancer, Non-Small Cell

Interventions

PROCEDURE

Collection of tumor and blood samples

Samples will be collected before and after standard treatment

Trial Locations (34)

12200

GSK Investigational Site, Berlin

13274

GSK Investigational Site, Marseille

13385

GSK Investigational Site, Marseille

17487

GSK Investigational Site, Greifswald

20141

GSK Investigational Site, Milan

20246

GSK Investigational Site, Hamburg

21079

GSK Investigational Site, Dijon

22927

GSK Investigational Site, Großhansdorf

24105

GSK Investigational Site, Kiel

30625

GSK Investigational Site, Hanover

34295

GSK Investigational Site, Montpellier

35128

GSK Investigational Site, Padua

44093

GSK Investigational Site, Nantes

49179

GSK Investigational Site, Ostercappeln

51109

GSK Investigational Site, Cologne

53100

GSK Investigational Site, Siena

55131

GSK Investigational Site, Mainz

58675

GSK Investigational Site, Hemer

59037

GSK Investigational Site, Lille

60068

GSK Investigational Site, Park Ridge

63110

GSK Investigational Site, St Louis

68167

GSK Investigational Site, Mannheim

69126

GSK Investigational Site, Heidelberg

72076

GSK Investigational Site, Tübingen

75012

GSK Investigational Site, Paris

79106

GSK Investigational Site, Freiburg im Breisgau

80131

GSK Investigational Site, Napoli

84107

GSK Investigational Site, Murray

90025

GSK Investigational Site, Los Angeles

93049

GSK Investigational Site, Regensburg

97080

GSK Investigational Site, Würzburg

SE-413 45

GSK Investigational Site, Gothenburg

SE-221 85

GSK Investigational Site, Lund

SE-171 76

GSK Investigational Site, Stockholm